PRPH: ProPhase Labs, Inc. Stock

by  •  • Comments Off on PRPH: ProPhase Labs, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 9.93
Enterprise Value ($M) 24.88
Book Value ($M) 38.13
Book Value / Share 1.60
Price / Book 0.26
NCAV ($M) -11.45
NCAV / Share -0.48
Price / NCAV -0.87

Profitability (mra)
Return on Invested Capital (ROIC) -0.42
Return on Assets (ROA) -0.30
Return on Equity (ROE) -0.56

Liquidity (mrq)
Quick Ratio 1.33
Current Ratio 1.47

Balance Sheet (mrq) ($M)
Current Assets 42.23
Assets 91.81
Liabilities 53.68
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-19 13D/A Karkus Ted William 20.30 2.79

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-10 111,768 535,525 20.87
2025-03-07 182,246 640,160 28.47
2025-03-06 218,502 979,166 22.32
2025-03-05 451,881 1,261,747 35.81

(click for more detail)

Similar Companies
PMN – ProMIS Neurosciences, Inc. PRFX – PainReform Ltd.
PROK – ProKidney Corp. PRQR – ProQR Therapeutics N.V.
PRTG – Portage Biotech Inc.


Financial data and stock pages provided by
Fintel.io